Sugano H, Kawaguchi T, Furusawa M, Ikawa Y
Bibl Haematol. 1975(40):221-8. doi: 10.1159/000397536.
A long-term cultured Friend leukemia cell is able to differentiate along the erythrocytic series following treatment with some substances and that can be demonstrated by a conjugated erythrocyte membrane-specific antibody technique. Differentiation is induced by inhibition of DNA synthesis and by dimethylsulfoxide (DMSO), erythropoietin (EP) and Vitamin B12 (B12), and other agents. The effective substances were divided into 2 groups by the mode of differentiation of Friend cells. A differentiated state continues for several days when cells are re-cultured in the medium without substances. The decreased tumorigenecity of differentiated cells is proved by back transplantation to mice.
长期培养的弗瑞德白血病细胞在用某些物质处理后能够沿着红细胞系分化,这可以通过一种结合红细胞膜特异性抗体技术来证明。分化是由DNA合成的抑制以及二甲基亚砜(DMSO)、促红细胞生成素(EP)、维生素B12(B12)和其他试剂诱导的。根据弗瑞德细胞的分化模式,有效物质被分为两组。当细胞在不含这些物质的培养基中重新培养时,分化状态会持续几天。将分化细胞回输到小鼠体内,证明其致瘤性降低。